<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02300194</url>
  </required_header>
  <id_info>
    <org_study_id>HGNPE-157</org_study_id>
    <nct_id>NCT02300194</nct_id>
  </id_info>
  <brief_title>Randomized, Double-blind, Placebo, Controlled Cross Over Design Topical Morphine for Analgesia in Pediatric Procedures</brief_title>
  <official_title>Topical Morphine for Analgesia in Pediatric Procedures. Clinical Trial Randomized, Double-blind, Placebo.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General de Niños Pedro de Elizalde</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General de Niños Pedro de Elizalde</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction:

      Opioids, such as morphine, act at receptors in the central nervous system, but many studies
      have suggested direct action peripherally on opioid receptors in sensory neurons terminals,
      melanocytes, keratinocytes and fibroblasts. These receptors are stimulated when occurs
      inflammatory processes.

      Hypothesis:

      Treatment with topical morphine 0.1% applied 30 minutes before an invasive procedure,
      decreases pain in children.

      Method:

      A randomised double-blind parallel study to evaluate the effect of topical application of a
      0.1% morphine gel in patients undergo a procedure. 22 patients in each group will be
      included. Randomly assigned to either the morphine gel or a placebo hydrogel, it will be
      applied 30 minutes before the procedure and the first day every 4 hours. General basic
      sedation and systemic analgesia will give for all the patients. Efficacy of treatment will be
      measured with &quot;Face, Legs, Activity, Cry, Consolability scale&quot; (FLACC scale).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The use of an opioid such as morphine topical gel 30 minutes before a procedure would be
      effective in reducing pain in children. It has proven effective analgesic with minimal
      adverse effects, especially in children older than 6 months, and even its use is authorized
      in young children.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Reduction</measure>
    <time_frame>4 hours</time_frame>
    <description>Proportion of patients with a reduction in pain of least 2 point according to FLACC scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Topic Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use of topic morphine for treatment of procedure associated pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Use of topic hydrogel (placebo) for treatment of procedure associated pain</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topic Morphine</intervention_name>
    <description>Topical application of a 0.1% morphine gel in patients undergo a procedure. It will be applied 30 minutes before the procedure and the first day every 4 hours. General basic sedation and systemic analgesia will give for all the patients. Efficacy of treatment will be measured with FLACC scale.</description>
    <arm_group_label>Topic Morphine</arm_group_label>
    <other_name>Morphine gel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Topical application of a placebo hydrogel in patients undergo a procedure. It will be applied 30 minutes before the procedure and the first day every 4 hours. General basic sedation and systemic analgesia will give for all the patients. Efficacy of treatment will be measured with FLACC scale.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Placebo hidrogel</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hospitalized children aged 1 month to 10 years, who needs a medical procedure over
             previously injured skin, associated with moderate-severe pain.

        Exclusion Criteria:

          -  Refusal to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>María L Yazde-Puleio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General de Niños Pedro de Elizalde</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fernando Ferrero</last_name>
    <phone>5443632100</phone>
    <phone_ext>1014</phone_ext>
    <email>fferrero@intramed.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital General de Niños Pedro de Elizalde</name>
      <address>
        <city>Ciudad Autonoma de Buenos Aires</city>
        <zip>C1270AAN</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando Ferrero, MD, PhD</last_name>
      <phone>+ 54 11 43632100</phone>
      <phone_ext>1014</phone_ext>
      <email>fferrero@intramed.net</email>
    </contact>
    <investigator>
      <last_name>María L Yazde-Puleio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <link>
    <url>http://apps.who.int/medicinedocs/documents/s19116es/s19116es.pdf</url>
    <description>World Health Organization 2012</description>
  </link>
  <reference>
    <citation>Garcia Roig C, Caprotta G, de Castro MF, Germ RM, Lagomarsino E. [Analgesia and sedation in pediatric procedures Part 1: general aspects, sedation scales and pain assessment]. Arch Argent Pediatr. 2008 Oct;106(5):429-34. doi: 10.1590/S0325-00752008000500010. Review. Spanish.</citation>
    <PMID>19030643</PMID>
  </reference>
  <reference>
    <citation>Shavit I, Keidan I, Augarten A. The practice of pediatric procedural sedation and analgesia in the emergency department. Eur J Emerg Med. 2006 Oct;13(5):270-5.</citation>
    <PMID>16969231</PMID>
  </reference>
  <reference>
    <citation>Nielsen BN, Aagaard G, Henneberg SW, Schmiegelow K, Hansen SH, Rømsing J. Topical morphine for oral mucositis in children: dose finding and absorption. J Pain Symptom Manage. 2012 Jul;44(1):117-23. doi: 10.1016/j.jpainsymman.2011.06.029. Epub 2012 Jun 1.</citation>
    <PMID>22658469</PMID>
  </reference>
  <reference>
    <citation>Heilmann S, Küchler S, Schäfer-Korting M. Morphine metabolism in human skin microsomes. Skin Pharmacol Physiol. 2012;25(6):319-22. doi: 10.1159/000342067. Epub 2012 Sep 8.</citation>
    <PMID>22964846</PMID>
  </reference>
  <reference>
    <citation>Ribeiro MD, Joel SP, Zeppetella G. The bioavailability of morphine applied topically to cutaneous ulcers. J Pain Symptom Manage. 2004 May;27(5):434-9.</citation>
    <PMID>15120772</PMID>
  </reference>
  <reference>
    <citation>Watterson G, Howard R, Goldman A. Peripheral opioids in inflammatory pain. Arch Dis Child. 2004 Jul;89(7):679-81.</citation>
    <PMID>15210505</PMID>
  </reference>
  <reference>
    <citation>Nilsson S, Finnström B, Kokinsky E. The FLACC behavioral scale for procedural pain assessment in children aged 5-16 years. Paediatr Anaesth. 2008 Aug;18(8):767-74. doi: 10.1111/j.1460-9592.2008.02655.x.</citation>
    <PMID>18613934</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2014</study_first_submitted>
  <study_first_submitted_qc>November 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2014</study_first_posted>
  <last_update_submitted>March 2, 2018</last_update_submitted>
  <last_update_submitted_qc>March 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pain management</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

